EUVIMEDEUVIMED entdecken
Querschnittstudie

Regarding: Adverse drug reaction reporting by New Zealand pharmacists: a cross-sectional investigation of community and hospital pharmacists

Lianne Parkin iD, Jennifer Lee, Ruth Savage, Susan Kenyon

International Journal of Pharmacy Practice · 14.08.2026

DOI: 10.1093/ijpp/riag097 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Pharmacy Practice, online erschienen am 14.08.2026. Verfasst von Lianne Parkin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Adverse Reactions Monitoring, New Zealand Pharmacovigilance Centre, University of Otago-Ōtākou Whakaihu Waka, Dunedin 9054, New Zealand. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Centre for Adverse Reactions Monitoring, New Zealand Pharmacovigilance Centre, University of Otago-Ōtākou Whakaihu Waka, Dunedin 9054, New Zealand.
  • Medsafe, Ministry of Health, Wellington 9054, New Zealand.

ORCID-Profile: Lianne Parkin

Zitieren

APA

Parkin, L., Lee, J., Savage, R., & Kenyon, S. (2026). Regarding: Adverse drug reaction reporting by New Zealand pharmacists: a cross-sectional investigation of community and hospital pharmacists. International Journal of Pharmacy Practice. https://doi.org/10.1093/ijpp/riag097

Vancouver

Parkin L, Lee J, Savage R, Kenyon S. Regarding: Adverse drug reaction reporting by New Zealand pharmacists: a cross-sectional investigation of community and hospital pharmacists. International Journal of Pharmacy Practice. 2026. doi:10.1093/ijpp/riag097

BibTeX
@article{Parkin2026,
  author = {Parkin, Lianne and Lee, Jennifer and Savage, Ruth and Kenyon, Susan},
  title = {Regarding: Adverse drug reaction reporting by New Zealand pharmacists: a cross-sectional investigation of community and hospital pharmacists},
  journal = {International Journal of Pharmacy Practice},
  year = {2026},
  doi = {10.1093/ijpp/riag097}
}
Kostenlos starten →